Stay updated on Pegzilarginase and Pembrolizumab in Small Cell Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the Pegzilarginase and Pembrolizumab in Small Cell Lung Cancer Clinical Trial page.

Latest updates to the Pegzilarginase and Pembrolizumab in Small Cell Lung Cancer Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe page’s revision label was updated from v3.6.2 to v3.6.3. This indicates a small update to the page rather than new study information.SummaryDifference0.0%

- Check16 days agoChange DetectedThe page revision changed from v3.6.0 to v3.6.2, signaling a small maintenance update rather than changes to the study content.SummaryDifference0.0%

- Check30 days agoChange DetectedThe page now indicates that recruitment has closed and adds several help/navigation items, along with a label formatting change for Intervention/Treatment and an update from revision v3.5.5 to v3.6.0.SummaryDifference0.4%

- Check37 days agoChange DetectedThe revision history shows the page updated from v3.5.4 to v3.5.5, indicating a minor metadata update to the ClinicalTrials.gov record.SummaryDifference0.0%

- Check59 days agoChange DetectedThe page's revision tag was updated from v3.5.3 to v3.5.4, indicating a new release of the page metadata. No study content or user-facing features are indicated to be affected by this update.SummaryDifference0.0%

- Check80 days agoChange DetectedThe page’s revision/version indicator was updated from v3.5.2 to v3.5.3, reflecting a change to the site software/document rendering version rather than the clinical trial information.SummaryDifference0.0%

Stay in the know with updates to Pegzilarginase and Pembrolizumab in Small Cell Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pegzilarginase and Pembrolizumab in Small Cell Lung Cancer Clinical Trial page.